Andover, Mass.
The Eisai Research Institute of Boston, a biopharmaceutical research firm, is planning a $50-million expansion and consolidation project in Andover, Mass. Eisai will break ground in late summer of 2004 on a 150,000-sf facility replacing a 66,825-sf office sited adjacent to the company’s existing 40,000-sf drug discovery facility. A new 5,000-sf addition is also included in the project, which involves the consolidation and relocation of Eisai’s Wilmington lab space to the new facility when it opens in 2006. The Eisai Research Institute of Boston is an Andover subsidiary of a Japanese pharmaceutical company.
